Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA

被引：0
|
作者：
Lang Zheng
Wenjing Wang
Qiu Sun
机构：
[1] West China Hospital,Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy
[2] Sichuan University,West China Medical Publishers, West China Hospital
[3] Sichuan University,undefined
来源：
Signal Transduction and Targeted Therapy | / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA
    Zheng, Lang
    Wang, Wenjing
    Sun, Qiu
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [2] Approvals by the China NMPA in 2023
    Xiecheng Zhi
    Qiu Li
    Liming Shao
    [J]. Nature Reviews Drug Discovery, 2024, 23 : 164 - 165
  • [3] Approvals by the China NMPA in 2023
    Zhi, Xiecheng
    Li, Qiu
    Shao, Liming
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (03) : 164 - 165
  • [4] 2023 FDA approvals
    Asher Mullard
    [J]. Nature Reviews Drug Discovery, 2024, 23 (2) : 88 - 95
  • [5] FDA new drug approvals in Q2 2023
    Urquhart, Lisa
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (08) : 614 - 614
  • [6] Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023
    Martins, Alexander C.
    Oshiro, Mariana Y.
    Albericio, Fernando
    de la Torre, Beatriz G.
    [J]. BIOMEDICINES, 2024, 12 (09)
  • [7] FDA new drug approvals in Q2 2023
    Lisa Urquhart
    [J]. Nature Reviews Drug Discovery, 2023, 22 : 614 - 614
  • [8] FDA new drug approvals in Q1 2023
    Urquhart, Lisa
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (05) : 346 - 346
  • [9] FDA new drug approvals in Q1 2023
    Lisa Urquhart
    [J]. Nature Reviews Drug Discovery, 2023, 22 : 346 - 346
  • [10] FDA new drug approvals in Q3 2023
    Verdin, Paul
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (12) : 946 - 946
12345